MBX Financial Statements From 2010 to 2026

MBX Stock   31.54  0.64  2.07%   
MBX Biosciences' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing MBX Biosciences' valuation are provided below:
Market Capitalization
1.4 B
Earnings Share
7.67
We have found one hundred thirteen available fundamental ratios for MBX Biosciences, which can be analyzed and compared to other ratios and to its peers in the industry. All investors should make sure to check all of MBX Biosciences last-minute market performance against the performance between 2010 and 2026 to make sure the company can sustain itself next year. Enterprise Value is likely to rise to about 740.3 M in 2026
Check MBX Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among MBX Biosciences' main balance sheet or income statement drivers, such as Net Interest Income of 7.6 M, Interest Income of 7.6 M or Depreciation And Amortization of 167.6 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 2.26. MBX financial statements analysis is a perfect complement when working with MBX Biosciences Valuation or Volatility modules.
  
Build AI portfolio with MBX Stock
Check out the analysis of MBX Biosciences Correlation against competitors.

MBX Biosciences Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets324.3 M308.8 M92.5 M
Slightly volatile
Short and Long Term Debt Total254.9 K153.9 K405.7 K
Slightly volatile
Other Current Liabilities3.8 M6.4 M2.8 M
Slightly volatile
Total Current Liabilities6.7 M12.7 M4.6 M
Slightly volatile
Property Plant And Equipment Net992.2 K1.4 M893 K
Slightly volatile
Accounts Payable6.4 M6.1 M1.9 M
Slightly volatile
Cash38.2 M56.8 M28.8 M
Slightly volatile
Non Current Assets TotalM1.4 M937.4 K
Slightly volatile
Non Currrent Assets Other52.1 K57.5 K44.4 K
Slightly volatile
Cash And Short Term Investments316.5 M301.5 M89 M
Slightly volatile
Net Receivables823.5 K784.3 K255.5 K
Slightly volatile
Common Stock Shares Outstanding35.6 M38.4 M32.5 M
Slightly volatile
Short Term Investments257 M244.7 M58.9 M
Slightly volatile
Liabilities And Stockholders Equity324.3 M308.8 M92.5 M
Slightly volatile
Non Current Liabilities Total35.9 K37.8 K73.4 M
Slightly volatile
Capital Lease Obligations254.9 K153.9 K405.7 K
Slightly volatile
Other Current Assets3.2 M5.1 M2.1 M
Slightly volatile
Other Stockholder Equity476.8 M454.1 M78.5 M
Slightly volatile
Total Liabilities9.5 M10 M78.1 M
Slightly volatile
Property Plant And Equipment Gross1.2 M1.9 MM
Slightly volatile
Total Current Assets322.7 M307.4 M91.5 M
Slightly volatile
Accumulated Other Comprehensive Income43.3 K63.2 K15.3 K
Slightly volatile
Capital StockK5.8 K1.8 K
Slightly volatile
Non Current Liabilities Other35.9 K37.8 K68.7 K
Very volatile
Net Working Capital309.4 M294.7 M86.5 M
Slightly volatile
Short Term Debt169 K196.7 K145.3 K
Slightly volatile
Common StockK5.8 K1.8 K
Slightly volatile

MBX Biosciences Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Interest Income7.6 M7.2 M1.7 M
Slightly volatile
Depreciation And Amortization167.6 K280.6 K92.8 K
Slightly volatile
Selling General Administrative7.8 M12.4 M5.1 M
Slightly volatile
Other Operating Expenses47.2 M78.4 M32.7 M
Slightly volatile
Research Development39.4 M66 M27.6 M
Slightly volatile
Cost Of Revenue167.6 K280.6 K92.8 K
Slightly volatile
Total Operating Expenses47.2 M78.4 M32.7 M
Slightly volatile
Reconciled Depreciation167.6 K280.6 K92.8 K
Slightly volatile

MBX Biosciences Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Change In Cash13.4 M21.7 M12.4 M
Slightly volatile
Stock Based Compensation6.3 MM1.4 M
Slightly volatile
Begin Period Cash Flow24.7 M35.1 M16.4 M
Slightly volatile
Other Cashflows From Financing Activities60.4 M68.5 M42.7 M
Slightly volatile
Depreciation167.6 K280.6 K92.8 K
Slightly volatile
Capital Expenditures529.5 KM486.5 K
Slightly volatile
Issuance Of Capital Stock287.4 M273.7 M78.9 M
Slightly volatile
Total Cash From Financing Activities282.7 M269.2 M85.5 M
Slightly volatile
End Period Cash Flow38.2 M56.8 M28.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Capex To Depreciation4.54.126.7882
Slightly volatile
Payables Turnover0.07920.05260.061
Slightly volatile
Cash Per Share7.427.072.4825
Slightly volatile
Days Payables Outstanding4.7 K7.2 K6.2 K
Pretty Stable
Income Quality1.011.020.9057
Slightly volatile
Net Debt To EBITDA0.920.830.9026
Slightly volatile
Current Ratio15.5521.7714.7224
Slightly volatile
Capex Per Share0.02470.02360.0152
Slightly volatile
Interest Debt Per Share0.00560.00590.0216
Slightly volatile
Debt To Assets7.0E-47.0E-40.0082
Slightly volatile
Days Of Payables Outstanding4.7 K7.2 K6.2 K
Pretty Stable
Ebt Per Ebit1.061.041.0255
Slightly volatile
Quick Ratio15.5521.7714.7224
Slightly volatile
Cash Ratio7.075.146.8342
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.111.171.0322
Slightly volatile
Debt Ratio7.0E-47.0E-40.0082
Slightly volatile

MBX Biosciences Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap778.1 M707.7 M744 M
Slightly volatile
Enterprise Value740.3 M651.2 M715.6 M
Slightly volatile

MBX Fundamental Market Drivers

About MBX Biosciences Financial Statements

MBX Biosciences investors use historical fundamental indicators, such as MBX Biosciences' revenue or net income, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in MBX Biosciences. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue280.6 K167.6 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for MBX Stock Analysis

When running MBX Biosciences' price analysis, check to measure MBX Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MBX Biosciences is operating at the current time. Most of MBX Biosciences' value examination focuses on studying past and present price action to predict the probability of MBX Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MBX Biosciences' price. Additionally, you may evaluate how the addition of MBX Biosciences to your portfolios can decrease your overall portfolio volatility.